Sage Journals: Discover world-class research

Open access

Case report

First published 2019

Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer

Sasan Fazeli, Edina Paal, Jessica H. Maxwell [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2025

Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy

Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

Arjun Khunger, Monica Khunger, Vamsidhar Velcheti

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2018-03

Circulating BRAF V600E Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Carrie C. Lubitz, Tiannan Zhan, Viswanath Gunda [...]

Thyroid®

Retricted access

Research article

First published 2023-10

Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer

Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu [...]

Thyroid®

Open access

Research article

First published 2022

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors

Ting Xu, Xicheng Wang, Zhenghang Wang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2015-1

BRAF Mutations are Also Associated with Neurocutaneous Melanocytosis and Large/Giant Congenital Melanocytic Nevi

Cláudia M. Salgado, Dipanjan Basu, Marina Nikiforova [...]

Pediatric and Developmental Pathology

Retricted access

Research article

First published 2017-05

NADPH Oxidase NOX4 Is a Critical Mediator of BRAF V600E -Induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas

Naïma Azouzi, Jérémy Cailloux, Juliana M. Cazarin [...]

Antioxidants & Redox Signaling

Open access

Review article

First published 2022

Encorafenib plus cetuximab for the treatment of BRAF-V600E -mutated metastatic colorectal cancer

Javier Ros, Nadia Saoudi, Iosune Baraibar [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2020-09

Acquired Secondary RAS Mutation in BRAF V600E -Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

Maria E. Cabanillas, Ramona Dadu, Pryianka Iyer [...]

Thyroid®

Search results